ZA956228B - 2- (2- amino - 1,6 - dihydro-6-oxo-purin-9-y1)methoxy-1,3-propanediol derivative - Google Patents

2- (2- amino - 1,6 - dihydro-6-oxo-purin-9-y1)methoxy-1,3-propanediol derivative

Info

Publication number
ZA956228B
ZA956228B ZA956228A ZA956228A ZA956228B ZA 956228 B ZA956228 B ZA 956228B ZA 956228 A ZA956228 A ZA 956228A ZA 956228 A ZA956228 A ZA 956228A ZA 956228 B ZA956228 B ZA 956228B
Authority
ZA
South Africa
Prior art keywords
purin
dihydro
oxo
methoxy
amino
Prior art date
Application number
ZA956228A
Other languages
English (en)
Inventor
John J Nestor
Scott W Womble
Hans Maag
Original Assignee
Hoffman La Roche A G F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA956228(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffman La Roche A G F filed Critical Hoffman La Roche A G F
Publication of ZA956228B publication Critical patent/ZA956228B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
ZA956228A 1994-07-28 1995-07-26 2- (2- amino - 1,6 - dihydro-6-oxo-purin-9-y1)methoxy-1,3-propanediol derivative ZA956228B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28189394A 1994-07-28 1994-07-28

Publications (1)

Publication Number Publication Date
ZA956228B true ZA956228B (en) 1996-02-22

Family

ID=23079211

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956228A ZA956228B (en) 1994-07-28 1995-07-26 2- (2- amino - 1,6 - dihydro-6-oxo-purin-9-y1)methoxy-1,3-propanediol derivative

Country Status (33)

Country Link
EP (1) EP0694547B1 (fr)
JP (1) JP3090305B2 (fr)
KR (1) KR100358626B1 (fr)
CN (1) CN1045089C (fr)
AT (1) ATE179173T1 (fr)
AU (1) AU697107B2 (fr)
BR (1) BR9503468A (fr)
CA (1) CA2154721C (fr)
CO (1) CO4410181A1 (fr)
CY (2) CY2180B1 (fr)
CZ (1) CZ290511B6 (fr)
DE (3) DE69509173T2 (fr)
DK (1) DK0694547T3 (fr)
ES (1) ES2083348T3 (fr)
FI (1) FI112080B (fr)
GR (2) GR960300021T1 (fr)
HK (1) HK1012339A1 (fr)
HU (1) HU216867B (fr)
IL (1) IL114735A (fr)
LU (1) LU91136I2 (fr)
MA (1) MA23631A1 (fr)
MY (1) MY114393A (fr)
NL (1) NL300071I2 (fr)
NO (2) NO312899B1 (fr)
NZ (1) NZ272652A (fr)
PE (1) PE32296A1 (fr)
PL (1) PL180609B1 (fr)
RU (1) RU2133749C1 (fr)
SA (1) SA95160158B1 (fr)
TR (1) TR199500895A2 (fr)
TW (1) TW434242B (fr)
UY (1) UY24006A1 (fr)
ZA (1) ZA956228B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
ES2180923T5 (es) * 1996-01-26 2005-10-16 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de purina.
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
WO1997027194A1 (fr) * 1996-01-26 1997-07-31 F. Hoffmann-La Roche Ag Procede pour preparer des derives de la purine
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US6184376B1 (en) 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
ATE227289T1 (de) * 1997-02-10 2002-11-15 Medivir Ab Verfahren zur herstellung von azyklischen nukleosiden
DK0988304T3 (da) * 1997-08-15 2001-08-20 Medivir Ab Nukleosidanaloger såsom antivirale midler omfattende inhibitorer af retroviral revers transkriptase og DNA-polymerasen fra hepatitis B-virus (HBV)
WO1999032490A1 (fr) * 1997-12-19 1999-07-01 Bristol-Myers Squibb Company Promedicaments du lobucavir et leur mode d'utilisation
WO1999051613A1 (fr) * 1998-04-03 1999-10-14 Medivir Ab Promedicaments de produits pharmaceutiques contenant du phosphore
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
AU2003239150A1 (en) * 2002-04-23 2003-11-10 Aventis Pharmaceuticals Inc. 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo
EP1552833B1 (fr) 2002-10-16 2016-12-28 Takeda Pharmaceutical Company Limited Procédé de préparation d'un iosmère optiquement actif du lansoprazole
ES2308136T3 (es) 2003-01-14 2008-12-01 Gilead Sciences, Inc. Composiciones y procedimientos para la politerapia antiviral.
CA2537132A1 (fr) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Chlorhydrate de valganciclovir amorphe
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
EP2626368B1 (fr) * 2004-07-19 2016-12-21 Biocon Limited Conjugués insuline-oligomère, formulations et utilisations de ceux-ci
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
JP5629581B2 (ja) 2007-10-12 2014-11-19 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 食物の摂取から独立した消化器疾患の治療方法
WO2012163373A1 (fr) * 2011-05-31 2012-12-06 Pharmathen S.A. Procédé de préparation d'un composé de 2-amino-9-((2-phényl-1,3-dioxan- 5-yloxy)-méthyl)-1h-purin-6(9h)-one utile dans la préparation du valganciclovir
KR102312533B1 (ko) 2021-02-24 2021-10-15 주식회사 이웅 자동 스패너

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
KR910000198B1 (ko) * 1984-12-12 1991-01-23 신텍스(유.에스.에이.) 인코포레이티드 글리세롤의 알콕시메틸 에테르 및 알콕시메틸 에스테르의 제조방법
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
AU618436B2 (en) * 1988-12-19 1991-12-19 Wellcome Foundation Limited, The Antiviral cytosine and guanine derivatives

Also Published As

Publication number Publication date
SA95160158B1 (ar) 2006-05-20
HU9502238D0 (en) 1995-09-28
CN1045089C (zh) 1999-09-15
AU697107B2 (en) 1998-09-24
MY114393A (en) 2002-10-31
ES2083348T1 (es) 1996-04-16
TW434242B (en) 2001-05-16
ATE179173T1 (de) 1999-05-15
IL114735A0 (en) 1995-11-27
IL114735A (en) 1998-06-15
ES2083348T3 (es) 1999-08-01
CZ290511B6 (cs) 2002-08-14
DE694547T1 (de) 1996-10-24
DE69509173D1 (de) 1999-05-27
CO4410181A1 (es) 1997-01-09
FI953592A (fi) 1996-01-29
NZ272652A (en) 1996-12-20
HUT73246A (en) 1996-07-29
CN1122804A (zh) 1996-05-22
CZ193995A3 (en) 1996-02-14
UY24006A1 (es) 2001-07-31
AU2719595A (en) 1996-02-08
NO2003001I2 (no) 2007-06-11
CY2004003I2 (el) 2009-11-04
RU95113148A (ru) 1997-06-27
KR100358626B1 (ko) 2003-01-14
FI112080B (fi) 2003-10-31
TR199500895A2 (tr) 1996-06-21
MA23631A1 (fr) 1996-04-01
DK0694547T3 (da) 2000-01-03
CY2180B1 (en) 2002-08-23
NL300071I2 (nl) 2002-03-01
GR960300021T1 (en) 1996-04-30
NO952977D0 (no) 1995-07-27
PL309812A1 (en) 1996-02-05
CA2154721C (fr) 2001-01-02
NO312899B1 (no) 2002-07-15
HU216867B (hu) 1999-09-28
NL300071I1 (nl) 2002-02-01
NO952977L (no) 1996-01-29
CA2154721A1 (fr) 1996-01-29
KR960004345A (ko) 1996-02-23
CY2004003I1 (el) 2009-11-04
RU2133749C1 (ru) 1999-07-27
PL180609B1 (pl) 2001-03-30
EP0694547B1 (fr) 1999-04-21
DE10299032I2 (de) 2006-06-14
GR3030678T3 (en) 1999-11-30
JP3090305B2 (ja) 2000-09-18
EP0694547A2 (fr) 1996-01-31
LU91136I2 (fr) 2005-07-06
BR9503468A (pt) 1996-02-27
DE10299032I1 (de) 2003-01-23
FI953592A0 (fi) 1995-07-27
PE32296A1 (es) 1996-08-07
EP0694547A3 (fr) 1996-06-05
DE69509173T2 (de) 1999-10-21
JPH0841061A (ja) 1996-02-13
HK1012339A1 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
CY2180B1 (en) 2-(2Amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
FI20020059A (fi) Enantiomeeripuhtaat diatsabisyklo/4.3.0/nonaanijohdannaiset
AU7820491A (en) Substituted Phthalides and Heterocyclic Phthalides and derivatives thereof.
HK1066010A1 (en) Optically active compounds which are useful as intermediates in the preparation of optically acitve-2-imidazoline-5-thione derivatives
EP0563345A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
ES2119912T3 (es) Nuevos aminometilenpeptidos como inmunosupresores.
CA2244680A1 (fr) Procede pour la preparation de derives de la purine
ATE172985T1 (de) Sulfonamidaminomethylenderivate als immunsuppressiva
DE69312776D1 (de) Fungizide 3,4-Diaryl-(5H)-Furan-2-Onederivate
DE69611148D1 (de) Pyrrolo(4,3,2-de)chinolin-Derivat
LT2417B (lt) Mo budas vaiku astrios leukozes nepalankios eigos isaiskini
AU8803091A (en) Method for protecting the myocardium against ischemia
ITMI930017A0 (it) Composizione polimerizzabile per l'impreganzione di un supporto tessile, avente elevate caratteristiche tixotropiche